ArticlemSphere2025
Effect of urolithin A on intracellular survival of
Jing Bi, Li Song, Qinglong Guo, Xi Chen, Yaqi Gong, Haojia Wu, Fan Zhang, Jingbin Wang, Guoliang Zhang
Abstract read
In one paragraphArticle in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Jing Bi *National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southwest Medical University, Shenzhen, China.
Li Song *National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southwest Medical University, Shenzhen, China.
Qinglong Guo *National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southwest Medical University, Shenzhen, China.ORCID 0000-0003-2288-7071 Xi Chen *School of Public Health, Guangdong Medical University, Dongguan, China.
Yaqi GongSchool of Medicine, Southern University of Science and Technology, Shenzhen, China.
Haojia WuNational Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southwest Medical University, Shenzhen, China.
Fan ZhangNational Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southwest Medical University, Shenzhen, China.
Jingbin WangShenzhen Hospital of Guangzhou University of Chinese Medicine (Futian), Shenzhen, China.
Guoliang ZhangNational Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southwest Medical University, Shenzhen, China.ORCID 0000-0002-3617-5449 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Tuberculosis (TB), resulting from
Indexed as
Antitubercular AgentsAutophagyCoumarinsForkhead Box Protein O1Mycobacterium tuberculosisProto-Oncogene Proteins c-aktAnimalsHumansIsoniazidMacrophagesMiceMice, Inbred C57BLMicrobial ViabilityRAW 264.7 CellsSignal TransductionTuberculosis3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneAntitubercular AgentsCoumarinsForkhead Box Protein O1IsoniazidProto-Oncogene Proteins c-aktAKT-FOXO1 signaling pathwayautophagyHDTMycobacterium tuberculosisurolithin A
Identifiers
PMID40207917
PMCPMC12108056
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390